Akebia Therapeutics, Inc. (AKBA)
1.345
-0.02
(-1.10%)
USD |
NASDAQ |
Jan 20, 16:00
1.345
0.00 (0.00%)
After-Hours: 16:24
Akebia Therapeutics Total Liabilities (Quarterly): 322.56M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen, Inc. | 80.52B |
| Pfizer Inc. | 115.64B |
| Theravance Biopharma, Inc. | 182.78M |
| Zevra Therapeutics, Inc. | 136.95M |
| Organon & Co. | 12.65B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 364.15M |
| Shareholders Equity (Quarterly) | 41.59M |
| Debt to Equity Ratio | 5.128 |
| Current Ratio | 1.937 |
| Net Debt Paydown Yield | -3.00% |